Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 2
1993 3
1994 1
1995 1
1996 1
1997 1
1998 7
1999 5
2000 2
2001 2
2002 7
2003 3
2004 1
2005 1
2006 3
2007 7
2008 5
2009 2
2010 3
2011 4
2012 3
2013 9
2014 8
2015 11
2016 14
2017 11
2018 6
2019 11
2020 7
2021 10
2022 18
2023 8
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators. Pulido T, et al. N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917. N Engl J Med. 2013. PMID: 23984728 Free article. Clinical Trial.
2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout.
Lorenzo JPP, Sollano MHMZ, Salido EO, Li-Yu J, Tankeh-Torres SA, Wulansari Manuaba IAR, Rahman MM, Paul BJ, Mok MY, De Silva M, Padhan P, Lim AL, Marcial M, Vicera JJ, Haq SA, Salman S, Liyanage CK, Keen HI, Yew Kuang C, Wei JC, Hellmi RY, Chan CE Jr, Louthrenoo W. Lorenzo JPP, et al. Among authors: louthrenoo w. Int J Rheum Dis. 2022 Jan;25(1):7-20. doi: 10.1111/1756-185X.14266. Epub 2021 Dec 20. Int J Rheum Dis. 2022. PMID: 34931463
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landewé R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S; FUTURE 1 Study Group. Mease PJ, et al. N Engl J Med. 2015 Oct;373(14):1329-39. doi: 10.1056/NEJMoa1412679. N Engl J Med. 2015. PMID: 26422723 Free article. Clinical Trial.
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF; Asia-Pacific Lupus Collaboration. Franklyn K, et al. Among authors: louthrenoo w. Ann Rheum Dis. 2016 Sep;75(9):1615-21. doi: 10.1136/annrheumdis-2015-207726. Epub 2015 Oct 12. Ann Rheum Dis. 2016. PMID: 26458737
Emerging therapeutic options for refractory gout.
Jatuworapruk K, Louthrenoo W. Jatuworapruk K, et al. Among authors: louthrenoo w. Nat Rev Rheumatol. 2024 Feb;20(2):73-74. doi: 10.1038/s41584-023-01066-5. Nat Rev Rheumatol. 2024. PMID: 38102493 No abstract available.
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.
Katsumata Y, Inoue E, Harigai M, Cho J, Louthrenoo W, Hoi A, Golder V, Lau CS, Lateef A, Chen YH, Luo SF, Wu YJ, Hamijoyo L, Li Z, Sockalingam S, Navarra S, Zamora L, Hao Y, Zhang Z, Chan M, Oon S, Ng K, Kikuchi J, Takeuchi T, Goldblatt F, O'Neill S, Tugnet N, Law AHN, Bae SC, Tanaka Y, Ohkubo N, Kumar S, Kandane-Rathnayake R, Nikpour M, Morand EF; Asia-Pacific Lupus Collaboration. Katsumata Y, et al. Among authors: louthrenoo w. Ann Rheum Dis. 2024 Jul 15;83(8):998-1005. doi: 10.1136/ard-2023-225369. Ann Rheum Dis. 2024. PMID: 38423757
APLAR rheumatoid arthritis treatment recommendations.
Lau CS, Chia F, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, Li Z, Lichauco JJ, Louthrenoo W, Luo SF, Nash P, Ng CT, Park SH, Suryana BP, Suwannalai P, Wijaya LK, Yamamoto K, Yang Y, Yeap SS; Asia Pacific League of Associations for Rheumatology. Lau CS, et al. Among authors: louthrenoo w. Int J Rheum Dis. 2015 Sep;18(7):685-713. doi: 10.1111/1756-185X.12754. Int J Rheum Dis. 2015. PMID: 26334449 Review.
An insight into rheumatology in Thailand.
Louthrenoo W. Louthrenoo W. Nat Rev Rheumatol. 2015 Jan;11(1):55-61. doi: 10.1038/nrrheum.2014.142. Epub 2014 Sep 9. Nat Rev Rheumatol. 2015. PMID: 25201382 Review.
Ergotism Masquerading Systemic Vasculitis.
Jatuworapruk K, Kattipathanapong T, Kasitanon N, Louthrenoo W. Jatuworapruk K, et al. Among authors: louthrenoo w. J Clin Rheumatol. 2017 Aug;23(5):287-288. doi: 10.1097/RHU.0000000000000523. J Clin Rheumatol. 2017. PMID: 28661928 No abstract available.
168 results